Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Liabilities and Shareholders Equity (2016 - 2025)

Mesa Laboratories' Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $434.8 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity changed 0.35% year-over-year to $434.8 million; the TTM value through Dec 2025 reached $1.7 billion, down 2.27%, while the annual FY2025 figure was $433.3 million, 3.01% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $434.8 million at Mesa Laboratories, up from $430.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $741.8 million in Q4 2023 and bottomed at $430.4 million in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $610.8 million (2021), against an average of $572.5 million.
  • The largest annual shift saw Liabilities and Shareholders Equity soared 47.02% in 2021 before it crashed 41.58% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $721.7 million in 2021, then dropped by 8.14% to $663.0 million in 2022, then rose by 11.88% to $741.8 million in 2023, then plummeted by 41.58% to $433.3 million in 2024, then increased by 0.35% to $434.8 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Liabilities and Shareholders Equity are $434.8 million (Q4 2025), $430.4 million (Q3 2025), and $435.7 million (Q2 2025).